Journal of Lipid Research, Vol 38, 2383-2398, Copyright © 1997 by Lipid Research, Inc.

REVIEWS

Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid

CJ Hillard and WB Campbell
Department of Pharmacology, Medical College of Wisconsin, Milwaukee 53226, USA.

This review presents and explores the hypothesis that N- arachidonylethanolamine (AEA, also called anandamide) is synthesized in the brain and functions as an endogenous ligand of the cannabinoid receptor. Support for this hypothesis comes from in vitro experiments demonstrating that AEA binds and activates signaling through the cannabinoid receptor. In addition, in vivo AEA produces effects very similar to those of the classical agonists of the cannabinoid receptor. Evidence for the cellular synthesis and release of AEA is not as clear. Data are presented that suggest that AEA is synthesized via a two enzyme process. First, a novel phospholipid (N- arachidonylphosphatidylethanolamine) is formed by a calcium-dependent transacylase. This lipid is a substrate for a phosphodiesterase of the phospholipase D type which releases AEA. Although there is some evidence to support this hypothesis, it is clear that AEA is a very minor product of this enzymatic cascade. Several important questions remain to be answered, including whether the concentrations of AEA synthesized by cells are sufficient to support a signaling role in the brain.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Matas, A. Juknat, M. Pietr, Y. Klin, and Z. Vogel Anandamide Protects from Low Serum-induced Apoptosis via Its Degradation to Ethanolamine J. Biol. Chem., March 16, 2007; 282(11): 7885 - 7892. [Abstract] [Full Text] [PDF]

				S. Ambrosi, L. Ragni, A. Ambrosini, L. Paccamiccio, P. Mariani, R. Fiorini, E. Bertoli, and G. Zolese On the importance of anandamide structural features for its interactions with DPPC bilayers: effects on PLA2 activity J. Lipid Res., September 1, 2005; 46(9): 1953 - 1961. [Abstract] [Full Text] [PDF]

				Y. Segall, G. B. Quistad, S. E. Sparks, D. K. Nomura, and J. E. Casida Toxicological and Structural Features of Organophosphorus and Organosulfur Cannabinoid CB1 Receptor Ligands Toxicol. Sci., November 1, 2003; 76(1): 131 - 137. [Abstract] [Full Text] [PDF]

				S. T. Glaser, N. A. Abumrad, F. Fatade, M. Kaczocha, K. M. Studholme, and D. G. Deutsch Evidence against the presence of an anandamide transporter PNAS, April 1, 2003; 100(7): 4269 - 4274. [Abstract] [Full Text] [PDF]

				G. Petersen, K. D. Chapman, and H. S. Hansen A rapid phospholipase D assay using zirconium precipitation of anionic substrate phospholipids: application to N-acylethanolamine formation in vitro J. Lipid Res., September 1, 2000; 41(9): 1532 - 1538. [Abstract] [Full Text]

				C. J. Hillard Endocannabinoids and Vascular Function J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 27 - 32. [Abstract] [Full Text]

				B. Moesgaard, G. Petersen, J. W. Jaroszewski, and H. S. Hansen Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain: a 31P NMR and enzyme activity study J. Lipid Res., June 1, 2000; 41(6): 985 - 990. [Abstract] [Full Text]

				P. Sharpe and G. Smith Cannabis: Time for Scientific Evaluation of This Ancient Remedy? Anesth. Analg., February 1, 2000; 90(2): 237 - 237. [Full Text] [PDF]

				C. J. Hillard, S. Manna, M. J. Greenberg, R. DiCamelli, R. A. Ross, L. A. Stevenson, V. Murphy, R. G. Pertwee, and W. B. Campbell Synthesis and Characterization of Potent and Selective Agonists of the Neuronal Cannabinoid Receptor (CB1) J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1427 - 1433. [Abstract] [Full Text]

				D. G. Deutsch, S. T. Glaser, J. M. Howell, J. S. Kunz, R. A. Puffenbarger, C. J. Hillard, and N. Abumrad The Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide Hydrolase J. Biol. Chem., March 2, 2001; 276(10): 6967 - 6973. [Abstract] [Full Text] [PDF]

				L. De Petrocellis, T. Bisogno, M. Maccarrone, J. B. Davis, A. Finazzi-Agro, and V. Di Marzo The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism J. Biol. Chem., April 13, 2001; 276(16): 12856 - 12863. [Abstract] [Full Text] [PDF]

				A. Berger, G. Crozier, T. Bisogno, P. Cavaliere, S. Innis, and V. Di Marzo Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets PNAS, May 22, 2001; 98(11): 6402 - 6406. [Abstract] [Full Text] [PDF]